Kimberly Gentile, VP of Operations at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 5,000 shares at $21.29 ($110K) on 2017-12-01, disclosed to the SEC on 2017-12-05.
Open-market sale of $110k BHVN by VP of Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.29 | 2,002 | $43K | 38.8% |
| 2 | $22.42 | 2,798 | $63K | 57.0% |
| 3 | $23.04 | 200 | $5K | 4.2% |
| Total | $21.99 avg | 5,000 | $110K | 100% |
| Filing → |
| BHVN | SELL | 2020-06-17 | $1.7M | — | Filing → |
| BHVN | SELL | 2020-06-10 | $42K | — | Filing → |
| BHVN | SELL | 2019-11-22 | $2.7M | — | Filing → |